BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 30556986)

  • 1. Inflammatory bowel disease.
    Casey G
    Nurs N Z; 2017 Mar; 23(2):20-24. PubMed ID: 30556986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory bowel disease: between genetics and microbiota.
    Younis N; Zarif R; Mahfouz R
    Mol Biol Rep; 2020 Apr; 47(4):3053-3063. PubMed ID: 32086718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
    Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
    Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Intestinal Microbiota in Inflammatory Bowel Disease.
    Becker C; Neurath MF; Wirtz S
    ILAR J; 2015; 56(2):192-204. PubMed ID: 26323629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota as Therapeutic Targets.
    Xavier RJ
    Dig Dis; 2016; 34(5):558-65. PubMed ID: 27331403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic immunoglobulin responses to gut bacteria during inflammatory bowel disease.
    Rengarajan S; Vivio EE; Parkes M; Peterson DA; Roberson EDO; Newberry RD; Ciorba MA; Hsieh CS
    Gut Microbes; 2020 May; 11(3):405-420. PubMed ID: 31203722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of the human gut microbiome in inflammatory bowel disease.
    Halfvarson J; Brislawn CJ; Lamendella R; Vázquez-Baeza Y; Walters WA; Bramer LM; D'Amato M; Bonfiglio F; McDonald D; Gonzalez A; McClure EE; Dunklebarger MF; Knight R; Jansson JK
    Nat Microbiol; 2017 Feb; 2():17004. PubMed ID: 28191884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decade in review-IBD: IBD-genes, bacteria and new therapeutic strategies.
    Colombel JF
    Nat Rev Gastroenterol Hepatol; 2014 Nov; 11(11):652-4. PubMed ID: 25311475
    [No Abstract]   [Full Text] [Related]  

  • 9. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.
    Jostins L; Ripke S; Weersma RK; Duerr RH; McGovern DP; Hui KY; Lee JC; Schumm LP; Sharma Y; Anderson CA; Essers J; Mitrovic M; Ning K; Cleynen I; Theatre E; Spain SL; Raychaudhuri S; Goyette P; Wei Z; Abraham C; Achkar JP; Ahmad T; Amininejad L; Ananthakrishnan AN; Andersen V; Andrews JM; Baidoo L; Balschun T; Bampton PA; Bitton A; Boucher G; Brand S; Büning C; Cohain A; Cichon S; D'Amato M; De Jong D; Devaney KL; Dubinsky M; Edwards C; Ellinghaus D; Ferguson LR; Franchimont D; Fransen K; Gearry R; Georges M; Gieger C; Glas J; Haritunians T; Hart A; Hawkey C; Hedl M; Hu X; Karlsen TH; Kupcinskas L; Kugathasan S; Latiano A; Laukens D; Lawrance IC; Lees CW; Louis E; Mahy G; Mansfield J; Morgan AR; Mowat C; Newman W; Palmieri O; Ponsioen CY; Potocnik U; Prescott NJ; Regueiro M; Rotter JI; Russell RK; Sanderson JD; Sans M; Satsangi J; Schreiber S; Simms LA; Sventoraityte J; Targan SR; Taylor KD; Tremelling M; Verspaget HW; De Vos M; Wijmenga C; Wilson DC; Winkelmann J; Xavier RJ; Zeissig S; Zhang B; Zhang CK; Zhao H; ; Silverberg MS; Annese V; Hakonarson H; Brant SR; Radford-Smith G; Mathew CG; Rioux JD; Schadt EE; Daly MJ; Franke A; Parkes M; Vermeire S; Barrett JC; Cho JH
    Nature; 2012 Nov; 491(7422):119-24. PubMed ID: 23128233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of Saccharomyces boulardii as a treatment option in IBD.
    Sivananthan K; Petersen AM
    Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):465-475. PubMed ID: 29771163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent understanding of IBD pathogenesis: implications for future therapies.
    Kucharzik T; Maaser C; Lügering A; Kagnoff M; Mayer L; Targan S; Domschke W
    Inflamm Bowel Dis; 2006 Nov; 12(11):1068-83. PubMed ID: 17075348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The microbiome and inflammatory bowel disease.
    Glassner KL; Abraham BP; Quigley EMM
    J Allergy Clin Immunol; 2020 Jan; 145(1):16-27. PubMed ID: 31910984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiota and IBD: Current knowledge and future perspectives.
    Foppa C; Rizkala T; Repici A; Hassan C; Spinelli A
    Dig Liver Dis; 2024 Jun; 56(6):911-922. PubMed ID: 38008696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IBDs and the pediatric age: Their peculiarities and the involvement of the microbiota.
    Cococcioni L; Panelli S; Varotto-Boccazzi I; Carlo DD; Pistone D; Leccese G; Zuccotti GV; Comandatore F
    Dig Liver Dis; 2021 Jan; 53(1):17-25. PubMed ID: 33189590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?
    Hold GL; Smith M; Grange C; Watt ER; El-Omar EM; Mukhopadhya I
    World J Gastroenterol; 2014 Feb; 20(5):1192-210. PubMed ID: 24574795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phages and Their Role in Gastrointestinal Disease: Focus on Inflammatory Bowel Disease.
    Maronek M; Link R; Ambro L; Gardlik R
    Cells; 2020 Apr; 9(4):. PubMed ID: 32325706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin A Targets a Unique Subset of the Microbiota in Inflammatory Bowel Disease.
    Shapiro JM; de Zoete MR; Palm NW; Laenen Y; Bright R; Mallette M; Bu K; Bielecka AA; Xu F; Hurtado-Lorenzo A; Shah SA; Cho JH; LeLeiko NS; Sands BE; Flavell RA; Clemente JC
    Cell Host Microbe; 2021 Jan; 29(1):83-93.e3. PubMed ID: 33385335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiome structure and metabolic activity in inflammatory bowel disease.
    Franzosa EA; Sirota-Madi A; Avila-Pacheco J; Fornelos N; Haiser HJ; Reinker S; Vatanen T; Hall AB; Mallick H; McIver LJ; Sauk JS; Wilson RG; Stevens BW; Scott JM; Pierce K; Deik AA; Bullock K; Imhann F; Porter JA; Zhernakova A; Fu J; Weersma RK; Wijmenga C; Clish CB; Vlamakis H; Huttenhower C; Xavier RJ
    Nat Microbiol; 2019 Feb; 4(2):293-305. PubMed ID: 30531976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetics and immunopathogenesis of inflammatory bowel disease.
    Cho JH
    Nat Rev Immunol; 2008 Jun; 8(6):458-66. PubMed ID: 18500230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiota and mucosal defense in IBD: an update.
    Stange EF; Schroeder BO
    Expert Rev Gastroenterol Hepatol; 2019 Oct; 13(10):963-976. PubMed ID: 31603356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.